Literature DB >> 16937337

Reversibility of enantiotropically related polymorphic transformations from a practical viewpoint: thermal analysis of kinetically reversible/irreversible polymorphic transformations.

Kohsaku Kawakami1.   

Abstract

Although enantiotropically related polymorphic transitions are thermodynamically reversible with temperature and pressure, they may be observed as either reversible or irreversible in practical investigations. This behavior may be explained simply by a difference in the energy barrier for the transition. However, this difference may have a significant effect on strategy in formulation development. This article summarizes the characteristics of enantiotropic transitions with reference to the literature. Also provided are careful investigations of polymorphic transitions by thermal analysis, which is the most promising method to investigate transition behavior. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association.

Mesh:

Substances:

Year:  2007        PMID: 16937337     DOI: 10.1002/jps.20748

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Parallel thermal analysis technology using an infrared camera for high-throughput evaluation of active pharmaceutical ingredients: a case study of melting point determination.

Authors:  Kohsaku Kawakami
Journal:  AAPS PharmSciTech       Date:  2010-07-31       Impact factor: 3.246

2.  Isothermal crystallization of Imwitor 742 from supercooled liquid state.

Authors:  Kohsaku Kawakami
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Modelling temperature-dependent properties of polymorphic organic molecular crystals.

Authors:  Jonas Nyman; Graeme M Day
Journal:  Phys Chem Chem Phys       Date:  2016-11-16       Impact factor: 3.676

4.  Distinct pathways of solid-to-solid phase transitions induced by defects: the case of dl-me-thio-nine.

Authors:  Genpei Shi; Si Li; Peng Shi; Junbo Gong; Mingtao Zhang; Weiwei Tang
Journal:  IUCrJ       Date:  2021-05-08       Impact factor: 4.769

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.